Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitethecolumngroup.net
Phone415.865.2050
Emailinfo@thecolumngro...
Employees
DescriptionVenture capital Firm

Funds

Total$242M
Column Group II, 3/2010 $65.5M
Column Group II, 4/2014 $176M

Offices

HQ
1700 Owens Street
Suite 500
San Francisco, CA, 94158
USA

People

Managing Partner
Managing Partner and Founder
Managing Partner
Partner
Science Partner
Science Partner
Chief Financial Officer
Manager of Administration
Strategic Advisor

Tags

The Column Group

The Column Group is a leading venture capital firm dedicated to creating the next generation of biotechnology companies

Recent Milestones

Investments

Company Date Round Size Participants
Igenica 1/2014Series C$14M4
Immune Design 10/2013Series C$49M6
Aragon Pharmaceuticals 10/2012Series D$50M4
Carmot Therapeutics 7/2012Partial Close$500k1
Igenica 6/2012Series C$33M4
Nurix 5/2012Venture Round$3.1M2
Peloton Therapeutics 7/2011Series A$18M2
Cyterix Pharmaceuticals 6/2011Series A$9.2M2
Constellation Pharmaceuticals 6/2011Series B$15M5
Immune Design 7/2010Series B$32M5
Igenica 6/2010Series B$24M3
Constellation Pharmaceuticals 6/2010Series B$22.3M5
Aragon Pharmaceuticals 4/2010Series B$22M3
NGM Biopharmaceuticals 12/2009Series A$26.6M3
PTC Therapeutics 12/2009Private Equity$50M5
Constellation Pharmaceuticals 8/2009Series A$17.2M4
3-V Biosciences 7/2009Series B$30M3
Aragon Pharmaceuticals 5/2009Series A$8M2
Immune Design 7/2008Series A$18M3
Vaccsys 6/2008Venture Round$9M3

Videos

Sources

  1. SEC D (sec.gov) [edit]
  2. Column Group raises $176M for second fund (pehub.com) [edit]
  3. Igenica Raises $14M in Series C Financing (finsmes.com) [edit]
  4. Immune Design Closes an up to $49M Series C Financing (finsmes.com) [edit]
  5. Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers (prnewswire.com) [edit]
  6. SEC (sec.gov) [edit]
  7. Igenica Raises $33M in Series C Funding (finsmes.com) [edit]
  8. Nurix Garners $3,100,000 New Funding Round (xconomy.com) [edit]
  9. Peloton Therapeutics Completes $18M Series A Financing (finsmes.com) [edit]
  10. Cyterix Pharmaceutics Raises $9.2M in Series A Financing (finsmes.com) [edit]
  11. Constellation Pharmaceuticals Raises $15M in Series B Financing (finsmes.com) [edit]
  12. Immune Design Nabs $32M for Targeted Vaccines (xconomy.com) [edit]
  13. Igenica, Inc.: Series B $24M (onbiovc.com) [edit]
  14. SEC (sec.gov) [edit]
  15. Aragon Pharma readies first cancer trial after $22M B round (fiercebiotech.com) [edit]
  16. SEC D/A (sec.gov) [edit]
  17. PTC Therapeutics Raises 50M in Equity Financing (finsmes.com) [edit]
  18. Constellation Pharmaceuticals, Inc. Closes $17 Million in Funding (constellationpharma.com) [edit]
  19. 3-V Biosciences, Inc. Secures $30 Million in Series B Funding, Welcomes New Members to Board of Directors (3vbio.com) [edit]
  20. Aragon Pharmaceuticals, Inc.: Series A $8M (onbiovc.com) [edit]
  21. Immune Design Aiming To Make Vaccines That Work Better in a Single Shot (xconomy.com) [edit]
  22. Vaccsys raises $9 million for vaccine research (venturebeat.com) [edit]
Edit This Page
Last Edited 4/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy